ShareHope Medicine Co Ltd Cash Flow Quality Index

Latest as of December 2025: 2.19x

ShareHope Medicine Co Ltd cash flow quality index. ShareHope Medicine Co Ltd (8403) has a Cash Flow Quality Index of 2.19x as of December 2025. Operating cash flow of NT$113.37 Million exceeds net income of NT$51.76 Million, indicating high earnings quality where cash backs reported profits. Explore 8403 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

2.19x
Operating CF / Net Income

Operating Cash Flow

NT$113.37 Million
TWD

Net Income

NT$51.76 Million
TWD

Data as of

Dec 2025
Most recent filing

Cash Flow Quality Index of ShareHope Medicine Co Ltd (2017–2025)

Cash flow quality index of ShareHope Medicine Co Ltd from 2017 to 2025. Historical Cash Flow Quality Index for ShareHope Medicine Co Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. See net asset quality index of ShareHope Medicine Co Ltd to measure how much of total assets are equity-financed.

ShareHope Medicine Co Ltd Cash Flow Quality Index by Year (2017–2025)

ShareHope Medicine Co Ltd cash flow quality index by year from 2017 to 2025. Year-by-year earnings quality comparison for ShareHope Medicine Co Ltd. For the full cash flow conversion analysis, see ShareHope Medicine Co Ltd (8403) cash conversion ratio.

Year Quality Index Operating CF (TWD) Net Income YoY Change
2025 2.57x NT$364.12 Million NT$141.73 Million ▲ +92.8%
2024 1.33x NT$266.68 Million NT$200.10 Million ▼ -43.5%
2023 2.36x NT$257.13 Million NT$108.98 Million ▲ +7.9%
2022 2.19x NT$642.47 Million NT$293.95 Million ▲ +62.4%
2021 1.35x NT$360.10 Million NT$267.63 Million ▼ -10.2%
2020 1.50x NT$717.74 Million NT$479.10 Million ▼ -41.9%
2019 2.58x NT$502.62 Million NT$195.05 Million ▲ +1008.4%
2018 0.23x NT$33.91 Million NT$145.85 Million ▼ -53.9%
2017 0.50x NT$62.76 Million NT$124.37 Million —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.